Latest Financial News

Instil Bio pivots to acquisitions after clinical program collapse
Healthcare
15m ago

Instil Bio pivots to acquisitions after clinical program collapse

Biotech's $76.3M cash stash fuels speculative M&A strategy as internal pipeline vanishes

US Markets Tumble as Fed Futures Price Zero Rate Cuts for 2026
Market Analysis
19m ago

US Markets Tumble as Fed Futures Price Zero Rate Cuts for 2026

'Higher for longer' rate environment compresses equity valuations, driving sector rotation away from growth stocks

Coinbase drops 4.3% as Waters questions Fed's crypto approval
Stocks
34m ago

Coinbase drops 4.3% as Waters questions Fed's crypto approval

Lawmaker demands transparency on Kraken's 'limited master account' access to Federal Reserve payment rails

ADMA Biologics plunges 45% on fraud allegations, channel stuffing claims
Stocks
48m ago

ADMA Biologics plunges 45% on fraud allegations, channel stuffing claims

Multiple law firms investigate plasma-derived biotech after short seller report

Apple opens Siri to rival AI assistants in strategic iOS 27 overhaul
Technology
48m ago

Apple opens Siri to rival AI assistants in strategic iOS 27 overhaul

New Extensions system will let users route Siri queries to Google Gemini and Anthropic Claude, ending OpenAI exclusivity

US-China trade war escalates as new probes target technology manufacturing
Technology
2h ago

US-China trade war escalates as new probes target technology manufacturing

Section 301 investigations into semiconductors, autos and batteries risk supply chain disruptions as Beijing warns of countermeasures

AstraZeneca COPD drug trials succeed as shares fall to six-week low
Healthcare
3h ago

AstraZeneca COPD drug trials succeed as shares fall to six-week low

First-in-class IL-33 inhibitor Tozorakimab meets Phase III targets in two confirmatory studies, challenging Regeneron-Sanofi rival

MP Materials plunges 3.8% on Texas magnet plant announcement
Stocks
3h ago

MP Materials plunges 3.8% on Texas magnet plant announcement

$1.25 billion facility targets China's rare earth dominance despite mixed market reaction